Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Multiple omics analyses and experiments validation identify PRDX3 as a biomarker of prognosis and antioncogene in kidney clear cell carcinoma

Fig 2

PRDX3 and clinical prognosis in cancers.

A: Summary of correlations of PRDX3 with clinical prognosis using Kaplan-Meier and cox regressions (OS: overall survival; PFI: progression-free internal; DSS: disease specific survival; DFI: disease-free interval). The red R means risky, the blue P means protective, and the blank means no significance. B-E: Forest plot about the prognostic roles of PRDX3 in cancers: OS, PFI, DSS and DFI. The log 10 of hazard ratio (HR) is achieved. The red means the HR is > 1, and the green means the HR is < 1. There are no significances for these lines including zero.

Fig 2

doi: https://doi.org/10.1371/journal.pone.0345095.g002